VVT Med Inc. risk profile
77 Stretched several inputs deteriorating together
Measured 26 October 2026 from VVTM's filed statements. Recomputed nightly.
77 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 78 | Stretched | Easing | Drawdown from the 52-week high — 44.4% |
| Operating pressure | 82 | Acute | Worsening | Costs outgrowing revenue — +298.3 percentage points |
| Cash conversion | 100 | Acute | No prior period | Capital spending against operating cash — -0.00x |
| Leverage and coverage | 100 | Acute | Stable | Net debt to EBITDA |
| Competitive position | 62 | Stretched | No prior period | Operating-margin gap against peers — -5,434.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.